Saturday, 1 January 2011
K2 Pedia! | Profectus Biosciences' GENEVAX IL-12 Adjuvant Significantly Improves PDNA Vaccine Performance In Phase I Human Trial | Significantly, Vaccine, Phase, Adjuvant, Pdna, Biosciences, Profectus, Response, Rate, Clinical, Vaccineinduced, Improved, Genevax™, Study, Announced, Infection, Read, http://www.k2pedia.com/hiv--aids/110344-profectus-biosciences-genevax-il-12-adjuvant-significantly-improves-pdna-vaccine-performance-in-phase-i-human-trial
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment